The MITOL protein has been implicated in Parkinson's disease.
According to a new study, an FDA approved drug prevented the development of Parkinson's disese in mice genetically engineered to develop the neurodegenerative disorder.
Using stem cells derived from Parkinson's patients, researchers confirm mitochondrial changes.
